ADRA2C
MOLECULAR TARGETadrenoceptor alpha 2C
ADRA2C (adrenoceptor alpha 2C) is targeted by 76 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting ADRA2C
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
Showing top 50 of 76 compounds. Use the BiohacksAI search to explore all ADRA2C modulators.
About ADRA2C as a Drug Target
ADRA2C (adrenoceptor alpha 2C) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 76 compounds with documented ADRA2C interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
ADRA2C inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.